strate. Preloading OAT4-transfected HEK293 cells with ICA stimulated ES uptake by 18.3 ± 3.8%. Conclusion: The uptake of ICA across the basolateral membrane of PCTs occurs mainly by OAT1 and the efflux into the tubular lumen by OAT4.
Introduction
Renal ischemia is known to play an important role in the pathophysiology of acute kidney injury as well as in chronic kidney disease. The balance between hypoxia and normoxia is regulated by transcription factors, commonly named hypoxia-inducible factors (HIFs). Under normoxic conditions, constitutively expressed HIF-α subunits are hydroxylated by prolyl hydroxylases (PHDs) which leads to recognition and ubiquitination by the E3 ubiquitin ligase von Hippel-Lindau protein and subsequent degradation by the proteasome. Under hypoxia, hydroxylation does not occur due to the lack of molecular oxygen and HIF can accumulate in the cell. In the nucleus, HIF-α dimerizes with the HIF-β/aryl hydrocarbon receptor nuclear receptor subunit and induces the transcription of its target genes [1, 2] . HIF target genes are numerous, including enzymes of the glycolytic pathway, vascular endothelial growth factor and PHDs. PHDs are increasingly considered as promising therapeutic targets to improve kidney function in acute or chronic hypoxia [3, 4] . Recently, we showed that the 2-oxoglutarate (2-OG) analogues, N-oxalylglycine (NOG) and pyridine-2,4-dicarboxylic acid, were transported by the organic anion transporter 1 (OAT1) and thus enter proximal tubule cells (PCTs) and stabilize HIF-1α [5] . Two-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) acetic acid (ICA, FG-2216) is another promising drug in establishing renal function after acute kidney injury in animal models [6, 7] and has also been shown to improve erythropoietin production in healthy volunteers and patients suffering from end-stage renal disease [8] . Since ICA is structurally related to NOG ( fig. 1 ), we investigated whether this drug is a substrate for one of the OATs. OATs are potent drug transporters occurring preferentially in PCTs and transport a wide variety of structurally unrelated compounds such as antivirals, anti-neoplastics, non-steroidal anti-inflammatory drugs, β-lactam antibiotics, diuretics, sartanes as well as metabolite intermediates and endogenous compounds such as flavonoids or coumarins [9] [10] [11] [12] .
Concise Methods

Reagents and Chemicals
All chemicals were of analytical grade and were purchased from Sigma-Aldrich (Taufkirchen, Germany) or AppliChem (Darmstadt, Germany). The [ 3 H]-labeled compounds, p-aminohippurate (PAH), cGMP and estrone-3-sulfate (ES), were from Perkin Elmer (Rodgau, Germany). ICA was synthesized as described in Schley et al. [6] .
Cell Culture and Transport Experiments
OAT1-, OAT2-, OAT3-, OAT4-and vector-transfected HEK293 cells are used routinely in our laboratory and were prepared and treated as described previously [5, 13] . For transport measurements, cells were incubated at room temperature in Mammalian Ringer (MRi) that contained the [ 3 H]nuclide at the concentration indicated in the respective figure legend and various experimental conditions. ICA was dissolved in DMSO. Uptake was terminated at 5 min by removal of the radio-labeled medium and immediately washing 3 times with ice-cold PBS. Cells were dissolved in 0.5 ml 1 N NaOH by gently shaking for 120 min, and the [ 3 H]-content was determined by liquid scintillation counting (Tricarb 2810, Perkin Elmer). Protein quantification was performed by the Bradford assay [14] .
Statistics and Calculations
Data are provided as means ± SD. Unpaired 1-tailed Student's t tests were used to show statistical significant differences for the inhibition of the uptake of PAH, cGMP or ES by ICA or by transstimulation of ICA on OAT1-, OAT3-, OAT4-and vector-transfected HEK293 cells. Statistical significance was set to * * * at p < 0.001. The constants for half-maximal inhibition (IC 50 ) of PAH, cGMP and ES uptake by ICA were calculated using SigmaPlot software (Systat Software, San Jose, Calif., USA).
Results
In OAT1-, OAT2-and OAT3-expressing HEK293 cells, ICA at a concentration of 100 μ M reduced the uptake of the reference substrate PAH for OAT1, cGMP for OAT2 and ES for OAT3 from 2.31 ± 0.46, 0.232 ± 0.052 and 0.034 ± 0.052 pmol·mg Whereas OAT1, OAT2 and OAT3 are localized in the basolateral membrane, OAT4 is found in the luminal membrane of PCTs. The uptake of ES by OAT4 was only moderately inhibited by ICA (100 μ M ; fig. 3 a) ; ES uptake decreased from 0.050 ± 0.002 to 0.034 ± 0.004 pmol· mg -1 ·min -1 in the presence of 100 μ M ICA. To test whether ICA interacts from the intracellular side with OAT4, OAT4-and vector-transfected HEK293 cells were preloaded for 120 min at 37 ° C with 100 μ M ICA and subsequently the uptake of ES was measured for 5 min. This experimental design stimulated ES uptake in OAT4-transfected cells by 18.3 ± 3.8% from 0.088 ± 0.004 to 0.106 ± 0.010 pmol·mg -1 ·min -1 ( fig. 3 b) .
Discussion
Stabilization of HIF-1α by inhibition of PHDs is considered a potential therapy for anemia and renal ischemia. There exist 3 isoforms of the HIF PHD enzyme: PHD1, PHD2 and PHD3 [10] . PHDs are members of the dioxygenase family that require oxygen, iron and the tricarboxylic acid intermediate 2-OG for their catalytic activity. Among the PHDs, PHD2 is considered the most important one, because PHD2 knock-out mice are not viable and die between embryonic day 12.5 and 14.5 [3] . PHD2 is present mainly in the cytoplasm and has a substrate preference for HIF-1α [15, 16] . PHD inhibitors derived from 2-OG bind, similar to 2-OG, at the catalytic site of the enzyme as a substrate mimic [3] . A potent PHD2 inhibitor is ICA (FG-2216). Its inhibitory activity against the PHD2 enzyme was determined to be 0.3 μ M [17] or 3.9 μ M [18] , depending on the assay used.
The first step in renal secretion of organic anions is their uptake across the basolateral membrane of PCTs by one of the OATs (OAT1, OAT2 or OAT3). Since we recently identified NOG [5] as an OAT1 substrate, we speculated that ICA, due to its structural similarity to NOG, is also an OAT1 substrate. ICA turned out to be a very potent inhibitor of PAH uptake in OAT1-transfected HEK293 cells, exhibiting an IC 50 of 0.29 ± 0.05 μ M . In the former study, the IC 50 for NOG was determined to be 79.6 ± 10.2 μ M [5] , that is, the IC 50 for ICA is approximately 275 times smaller than the IC 50 for NOG in a similar experimental setup. of the plasma concentration of ICA (approximately 3-5 μ M ), which can be calculated from the maximal plasma concentration (C max 179 ± 31 μg/ml) given by Bernhardt et al. [8] . Efflux-or trans-stimulation experiments identified ICA as an OAT1 and an OAT3 substrate. However, due to the low stimulation of ES uptake by preloading OAT3-transfected cells with ICA, the contribution of OAT3 to ICA uptake may be low.
Whereas ICA is taken up primarily by OAT1, its release into the final urine is likely to be mediated by OAT4. In addition, ICA filtered by the glomerulus is able to block ES uptake by OAT4. The cooperation between inhibition by and transport of ICA by OAT4 may modulate intracellular ICA concentrations, thereby contributing to the beneficial effect of ICA on stabilizing HIF-1α. Beneficial effects of ICA were already demonstrated in mouse models of renal ischemia reperfusion injury, where application of ICA improved kidney structure and preserved renal function [6] . In a phase 1 study, ICA was applied orally to 12 hemodialysis patients, 6 of them anephric and 6 healthy volunteers [8] .
The area under the curve was 3,660 ± 813 in healthy volunteers and increased to 5,730 ± 2,420 and 6,572 ± 2,349 h/μg per ml in nephric and anephric patients. Similarly, the T 1/2 changed from 15.7 ± 1.1 to 29.8 ± 11.4 and 33.3 ± 8.4 h in the same cohorts [8] , and an increase in erythropoietin production in all subjects was observed. The increase in the area under the curve and in T 1/2 in anephric patients highlights the role of renal secretion of ICA, a process in which OATs are likely to be involved.
